354 related articles for article (PubMed ID: 17494576)
41. Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza.
Swayne DE
Ann N Y Acad Sci; 2006 Oct; 1081():174-81. PubMed ID: 17135509
[TBL] [Abstract][Full Text] [Related]
42. Protection Afforded by a Recombinant Turkey Herpesvirus-H5 Vaccine Against the 2014 European Highly Pathogenic H5N8 Avian Influenza Strain.
Steensels M; Rauw F; van den Berg T; Marché S; Gardin Y; Palya V; Lambrecht B
Avian Dis; 2016 May; 60(1 Suppl):202-9. PubMed ID: 27309056
[TBL] [Abstract][Full Text] [Related]
43. Impact of vaccination on infection with Vietnam H5N1 high pathogenicity avian influenza virus in hens and the eggs they lay.
Bertran K; Moresco K; Swayne DE
Vaccine; 2015 Mar; 33(11):1324-30. PubMed ID: 25657093
[TBL] [Abstract][Full Text] [Related]
44. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.
Connie Leung YH; Luk G; Sia SF; Wu YO; Ho CK; Chow KC; Tang SC; Guan Y; Malik Peiris JS
Vaccine; 2013 Aug; 31(35):3536-42. PubMed ID: 23791547
[TBL] [Abstract][Full Text] [Related]
45. Highly pathogenic avian influenza (H5N1) in ducks and in-contact chickens in backyard and smallholder commercial duck farms in Viet Nam.
Henning J; Henning KA; Morton JM; Long NT; Ha NT; Vu le T; Vu PP; Hoa DM; Meers J
Prev Vet Med; 2011 Sep; 101(3-4):229-40. PubMed ID: 20594603
[TBL] [Abstract][Full Text] [Related]
46. The adjuvant effect of Sophy β-glucan to the antibody response in poultry immunized by the avian influenza A H5N1 and H5N2 vaccines.
Le T; Le T; Doan TH; Quyen D; Le KX; Pham V; Nagataki M; Nomura H; Ikeue Y; Watanabe Y; Agatsuma T
J Microbiol Biotechnol; 2011 Apr; 21(4):405-11. PubMed ID: 21532325
[TBL] [Abstract][Full Text] [Related]
47. Protection of commercial turkeys following inactivated or recombinant H5 vaccine application against the 2015U.S. H5N2 clade 2.3.4.4 highly pathogenic avian influenza virus.
Kapczynski DR; Sylte MJ; Killian ML; Torchetti MK; Chrzastek K; Suarez DL
Vet Immunol Immunopathol; 2017 Sep; 191():74-79. PubMed ID: 28895870
[TBL] [Abstract][Full Text] [Related]
48. Reverse genetics based rgH5N2 vaccine provides protection against high dose challenge of H5N1 avian influenza virus in chicken.
Bhatia S; Khandia R; Sood R; Bhat S; Siddiqui A; Jahagirdhar G; Mishra S; Mishra A; Pateriya AK; Kulkarni DD
Microb Pathog; 2016 Aug; 97():172-7. PubMed ID: 27296706
[TBL] [Abstract][Full Text] [Related]
49. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
[TBL] [Abstract][Full Text] [Related]
50. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes.
Qiao CL; Yu KZ; Jiang YP; Jia YQ; Tian GB; Liu M; Deng GH; Wang XR; Meng QW; Tang XY
Avian Pathol; 2003 Feb; 32(1):25-32. PubMed ID: 12745375
[TBL] [Abstract][Full Text] [Related]
51. Protection against H7N3 high pathogenicity avian influenza in chickens immunized with a recombinant fowlpox and an inactivated avian influenza vaccines.
Bertran K; Sá E Silva M; Pantin-Jackwood MJ; Swayne DE
Vaccine; 2013 Aug; 31(35):3572-6. PubMed ID: 23707445
[TBL] [Abstract][Full Text] [Related]
52. Suboptimal protection against H5N1 highly pathogenic avian influenza viruses from Vietnam in ducks vaccinated with commercial poultry vaccines.
Cha RM; Smith D; Shepherd E; Davis CT; Donis R; Nguyen T; Nguyen HD; Do HT; Inui K; Suarez DL; Swayne DE; Pantin-Jackwood M
Vaccine; 2013 Oct; 31(43):4953-60. PubMed ID: 23994373
[TBL] [Abstract][Full Text] [Related]
53. Vaccines developed for H5 highly pathogenic avian influenza in China.
Qiao C; Tian G; Jiang Y; Li Y; Shi J; Yu K; Chen H
Ann N Y Acad Sci; 2006 Oct; 1081():182-92. PubMed ID: 17135510
[TBL] [Abstract][Full Text] [Related]
54. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638
[TBL] [Abstract][Full Text] [Related]
55. Conventional H5N9 vaccine suppresses shedding in specific-pathogen-free birds challenged with HPAI H5N1 A/chicken/Yamaguchi/7/2004.
Terregino C; Toffan A; Beato MS; De Nardi R; Drago A; Capua I
Avian Dis; 2007 Mar; 51(1 Suppl):495-7. PubMed ID: 17494617
[TBL] [Abstract][Full Text] [Related]
56. Comparison of the effectiveness of rHVT-H5, inactivated H5 and rHVT-H5 with inactivated H5 prime/boost vaccination regimes in commercial broiler chickens carrying MDAs against HPAI H5N1 clade 2.2.1 virus.
Kilany WH; Hassan MK; Safwat M; Mohammed S; Selim A; VonDobschuetz S; Dauphin G; Lubroth J; Jobre Y
Avian Pathol; 2015 Oct; 44(5):333-41. PubMed ID: 26023824
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of rHVT-AI vector vaccine in broilers with passive immunity against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.
Rauw F; Palya V; Gardin Y; Tatar-Kis T; Dorsey KM; Lambrecht B; van den Berg T
Avian Dis; 2012 Dec; 56(4 Suppl):913-22. PubMed ID: 23402112
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of Bivalent Inactivated Vaccine Containing Insect Cell-Expressed Avian Influenza H5 and Egg-Based Newcastle Disease Virus (NDV) Against Dual Infection with Highly Pathogenic H5N1 and Velogenic NDV in Chickens.
Said M; Soliman MA; Mousa S; Arafa A; Hussein HA; Amarin N; Mundt E
Avian Dis; 2019 Sep; 63(3):474-480. PubMed ID: 31967431
[TBL] [Abstract][Full Text] [Related]
59. Potency of a recombinant NDV-H5 vaccine against various HPAI H5N1 virus challenges in SPF chickens.
Lardinois A; Steensels M; Lambrecht B; Desloges N; Rahaus M; Rebeski D; van den Berg T
Avian Dis; 2012 Dec; 56(4 Suppl):928-36. PubMed ID: 23402114
[TBL] [Abstract][Full Text] [Related]
60. H5-based DNA constructs derived from selected highly pathogenic H5N1 avian influenza virus induce high levels of humoral antibodies in Muscovy ducks against low pathogenic viruses.
Guionie O; Niqueux E; Amelot M; Bougeard S; Jestin V
Virol J; 2014 Apr; 11():74. PubMed ID: 24762011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
